Cargando…

Development of novel vaccine candidates and challenge models for Plasmodium vivax

Detalles Bibliográficos
Autores principales:	Alves, Eduardo, Salman, Ahmed, Janse, Chris, Khan, Shahid, Hill, Adrian, Reyes-Sandoval, Arturo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179339/ http://dx.doi.org/10.1186/1475-2875-13-S1-P4

Ejemplares similares

Development of a Plasmodium vivax malaria vaccine for clinical applications using transgenic parasites, virus-like particles and recombinant viruses
por: Reyes-Sandoval, Arturo, et al.
Publicado: (2014)

Evaluation of Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites as a Preerythrocytic P. vivax Vaccine
por: Alves, Eduardo, et al.
Publicado: (2017)

Development of an in vitro Plasmodium parasite killing assay for the evaluation of cell-mediated immune responses following vaccination with pre-erythrocytic malaria vaccine candidates
por: Bliss, Carly M, et al.
Publicado: (2014)

Tailoring a Plasmodium vivax Vaccine To Enhance Efficacy through a Combination of a CSP Virus-Like Particle and TRAP Viral Vectors
por: Atcheson, Erwan, et al.
Publicado: (2018)

A novel Plasmodium vivax vaccine based on recombinant chimpanzee adenovirus ChAd63 and MVA expressing TRAP
por: Bauza, Karolis, et al.
Publicado: (2012)

A universal vaccine candidate against Plasmodium vivax malaria confers protective immunity against the three PvCSP alleles
por: Gimenez, Alba Marina, et al.
Publicado: (2021)

Plasmodium vivax pre-erythrocytic vaccines
por: Reyes-Sandoval, Arturo
Publicado: (2021)

Rational development of a protective P. vivax vaccine evaluated with transgenic rodent parasite challenge models
por: Salman, Ahmed M., et al.
Publicado: (2017)

Suppression of erythropoiesis by Plasmodium vivax infection
por: Panichakul, Tasanee, et al.
Publicado: (2010)

Plasmodium vivax malaria vaccines: Why are we where we are?
por: Reyes-Sandoval, Arturo, et al.
Publicado: (2013)

Chimeric Plasmodium falciparum parasites expressing Plasmodium vivax circumsporozoite protein fail to produce salivary gland sporozoites
por: Marin-Mogollon, Catherin, et al.
Publicado: (2018)

Generation of a Genetically Modified Chimeric Plasmodium falciparum Parasite Expressing Plasmodium vivax Circumsporozoite Protein for Malaria Vaccine Development
por: Miyazaki, Yukiko, et al.
Publicado: (2020)

Assessment of the Plasmodium falciparum Preerythrocytic Antigen UIS3 as a Potential Candidate for a Malaria Vaccine
por: Longley, Rhea J., et al.
Publicado: (2017)

Plasmodium falciparum, vivax and malariae detection during the low transmission season in the hill tracts of Bangladesh
por: Akter, Jasmin, et al.
Publicado: (2010)

Modeling the relapse distribution of Plasmodium vivax in different geographies
por: Eckhoff, Philip, et al.
Publicado: (2014)

Genetic diversity and the ensuing strain specific immunity to asexual erythrocytic stage vaccine candidate antigens, MSP-1, AMA-1 and DBP, of Plasmodium vivax in Sri Lanka
por: Udagama-Randeniya, Preethi, et al.
Publicado: (2010)

Cellular and humoral immune responses against the Plasmodium vivax MSP-1(19) malaria vaccine candidate in individuals living in a Brazilian endemic area in northeastern Amazon
por: Riccio, Evelyn Kety Pratt, et al.
Publicado: (2014)

Microsatellite characterization of Plasmodium vivax in pregnant women on the Thai–Myanmar border
por: Thanapongpichat, Supinya, et al.
Publicado: (2012)

Genetic variability of Plasmodium vivax from primary–relapses paired samples
por: Araujo, Flávia C, et al.
Publicado: (2012)

Protective efficacy of peptides from Plasmodium vivax circumsporozoite protein
por: Atcheson, Erwan, et al.
Publicado: (2020)

Distinct HLA class II alleles influence antibody response to the Plasmodium vivax Duffy binding protein
por: Kano, Flora S, et al.
Publicado: (2014)

Therapeutic efficacy of chloroquine and primaquine for Plasmodium vivax malaria treatment in southeast Iran
por: Heidari, Aliehsan, et al.
Publicado: (2012)

Overcoming challenges to discover drugs for liver stages of Plasmodium vivax
por: Kyle, Dennis E
Publicado: (2014)

Erythrocyte binding activity of Plasmodium vivax tryptophan rich antigens is inhibited by patients’ antibodies
por: Tyagi, Rupesh K, et al.
Publicado: (2012)

Efficacy of a Plasmodium vivax Malaria Vaccine Using ChAd63 and Modified Vaccinia Ankara Expressing Thrombospondin-Related Anonymous Protein as Assessed with Transgenic Plasmodium berghei Parasites
por: Bauza, Karolis, et al.
Publicado: (2014)

Characterization of the Plasmodium vivax erythrocytic stage proteome and identification of a potent immunogenic antigen of the asexual stages
por: Roobsoong, Wanlapa, et al.
Publicado: (2010)

Developmental transition of Plasmodium sporozoites into liver-stage forms is regulated by the RNA binding protein Pumilio 2
por: Gomes-Santos, Carina SS, et al.
Publicado: (2010)

Is the single variant form of Plasmodium vivax Duffy binding protein-II (PvDBP-II) adequate for inclusion in a PvDBP-II-based vaccine?
por: Valizadeh, Vahideh, et al.
Publicado: (2014)

Acquisition and Longevity of Antibodies to Plasmodium vivax Preerythrocytic Antigens in Western Thailand
por: Longley, Rhea J., et al.
Publicado: (2016)

Comparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidates
por: Longley, Rhea J., et al.
Publicado: (2015)

Preliminary characterization of Plasmodium vivax sporozoite antigens as pre-erythrocytic vaccine candidates
por: Nicholas, Justin, et al.
Publicado: (2023)

Plasmodium vivax infection: atypical memory B cells are expanded and associated with the persistence of Duffy binding protein II (DBPII) antibody response
por: Kano, Flora S, et al.
Publicado: (2014)

A VLP for validation of the Plasmodium falciparum circumsporozoite protein junctional epitope for vaccine development
por: Atcheson, Erwan, et al.
Publicado: (2021)

Plasmodium translationally repressed gene products are essential for parasite development and malaria transmission
por: Santos, Jorge M, et al.
Publicado: (2012)

Antigenic repertoire of Plasmodium vivax transmission-blocking vaccine candidates from the Indian subcontinent
por: Prajapati, Surendra K, et al.
Publicado: (2011)

Genetic diversity and population structure of genes encoding vaccine candidate antigens of Plasmodium vivax
por: Chenet, Stella M, et al.
Publicado: (2012)

What Is Known about the Immune Response Induced by Plasmodium vivax Malaria Vaccine Candidates?
por: López, Carolina, et al.
Publicado: (2017)

Evaluation of two Plasmodium vivax sexual stage antigens as transmission-blocking vaccine candidates
por: Zhang, Yongzhe, et al.
Publicado: (2021)

The challenges of Plasmodium vivax human malaria infection models for vaccine development
por: Roobsoong, Wanlapa, et al.
Publicado: (2023)

Dissection-independent production of Plasmodium sporozoites from whole mosquitoes
por: Blight, Joshua, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2o37bka67nfi1fnqjoavk4rmi9